Skip to content

Clinical trials

Observational Macular Degeneration trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Observational Country / region: China Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20172
20181
20192
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Completed2
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals1
Shanghai 10th People's Hospital1
Skyline Therapeutics1
Sun Yat-sen University1
The Eye Hospital of Wenzhou Medical University1
The First Affiliated Hospital with Nanjing Medical University1
Xun Xu1
Zhongmou Therapeutics1
Zhongshan Ophthalmic Center, Sun Yat-sen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration9
Diabetic Retinopathy2
Myopia, Degenerative2
Polypoidal Choroidal Vasculopathy2
Behcet Syndrome1
Choroid Diseases1
Choroidal Neovascularization1
Cognitive Dysfunction1
Color Vision Defects1
Retinal Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.